95 related articles for article (PubMed ID: 9490614)
1. [ELISA of IgM antibodies to Thomsen-Friedenreich (TF) hapten in cancer diagnostics: comparison of data obtained with four TF-glycoconjugates].
Smorodin EP; Jansson B; Miliukhina L; Paaski G; Bovin NV; Ovchinnikova TV; Kurtenkov O
Bioorg Khim; 1997 Oct; 23(10):795-9. PubMed ID: 9490614
[TBL] [Abstract][Full Text] [Related]
2. Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.
Smorodin EP; Kurtenkov OA; Sergeyev BL; Kodar KE; Chuzmarov VI; Afanasyev VP
World J Gastroenterol; 2008 Jul; 14(27):4352-8. PubMed ID: 18666325
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of thomsen-friedenreich-specific antibodies from human serum.
Butschak G; Karsten U
Tumour Biol; 2002; 23(3):113-22. PubMed ID: 12218291
[TBL] [Abstract][Full Text] [Related]
4. Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection.
Desai PR; Ujjainwala LH; Carlstedt SC; Springer GF
J Immunol Methods; 1995 Dec; 188(2):175-85. PubMed ID: 8551046
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers.
Longenecker BM; Willans DJ; MacLean GD; Selvaraj S; Suresh MR; Noujaim AA
J Natl Cancer Inst; 1987 Mar; 78(3):489-96. PubMed ID: 3469463
[TBL] [Abstract][Full Text] [Related]
6. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.
MacLean GD; Bowen-Yacyshyn MB; Samuel J; Meikle A; Stuart G; Nation J; Poppema S; Jerry M; Koganty R; Wong T
J Immunother (1991); 1992 May; 11(4):292-305. PubMed ID: 1599915
[TBL] [Abstract][Full Text] [Related]
7. Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.
Kodar K; Izotova J; Klaamas K; Sergeyev B; Järvekülg L; Kurtenkov O
World J Gastroenterol; 2013 Jun; 19(23):3573-82. PubMed ID: 23801858
[TBL] [Abstract][Full Text] [Related]
8. Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential.
Kurtenkov O; Izotova J; Klaamas K; Sergeyev B
Biomed Res Int; 2014; 2014():830847. PubMed ID: 25276822
[TBL] [Abstract][Full Text] [Related]
9. The level of IgG antibodies reactive to TF, Tn and alpha-Gal polyacrylamide-glycoconjugates in breast cancer patients: relation to survival.
Smorodin EP; Sergeyev BL
Exp Oncol; 2016 Jun; 38(2):117-21. PubMed ID: 27356581
[TBL] [Abstract][Full Text] [Related]
10. Specificity of human anti-carbohydrate IgG antibodies as probed with polyacrylamide-based glycoconjugates.
Smorodin EP; Kurtenkov OA; Sergeyev BL; Pazynina GV; Bovin NV
Glycoconj J; 2004; 20(2):83-9. PubMed ID: 15001840
[TBL] [Abstract][Full Text] [Related]
11. Use of synthetic antigens with the carbohydrate structure of asialoglycophorin A for the specification of Thomsen-Friedenreich antibodies.
Höppner W; Fischer K; Poschmann A; Paulsen H
Vox Sang; 1985; 48(4):246-53. PubMed ID: 3984310
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: relation to survival.
Kurtenkov O; Klaamas K; Mensdorff-Pouilly S; Miljukhina L; Shljapnikova L; Chuzmarov V
Acta Oncol; 2007; 46(3):316-23. PubMed ID: 17450466
[TBL] [Abstract][Full Text] [Related]
13. Human monoclonal antibodies specific for the tumour associated Thomsen-Friedenreich antigen.
Dahlenborg K; Hultman L; Carlsson R; Jansson B
Int J Cancer; 1997 Jan; 70(1):63-71. PubMed ID: 8985092
[TBL] [Abstract][Full Text] [Related]
14. Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer.
Kurtenkov O; Klaamas K
Dis Markers; 2015; 2015():761908. PubMed ID: 26663951
[TBL] [Abstract][Full Text] [Related]
15. The Thomsen-Friedenreich antigen and alphaGal-specific human IgG glycoforms: concanavalin A reactivity and relation to survival of cancer patients.
Kodar K; Kurtenkov O; Klaamas K
Immunol Invest; 2009; 38(8):704-17. PubMed ID: 19860583
[TBL] [Abstract][Full Text] [Related]
16. Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176, TF) antibodies: Evidence for a multiple TF epitope.
Flechner A; Butschak G; Löffler A; Rühmann J; Nishimura SI; Dölling R; Purfürst B; Goletz S; Danielczyk A; Karsten U
Int Immunopharmacol; 2019 Jul; 72():186-194. PubMed ID: 30999209
[TBL] [Abstract][Full Text] [Related]
17. Natural IgM and IgG antibodies to Thomsen-Friedenreich (T) antigen in serum of patients with gastric cancer and blood donors--relation to Lewis (a,b) histo-blood group phenotype.
Kurtenkov O; Miljukhina L; Smorodin J; Klaamas K; Bovin N; Ellamaa M; Chuzmarov V
Acta Oncol; 1999; 38(7):939-43. PubMed ID: 10606423
[TBL] [Abstract][Full Text] [Related]
18. The relation of the level of serum anti-TF, -Tn and -alpha-Gal IgG to survival in gastrointestinal cancer patients.
Smorodin E; Sergeyev B; Klaamas K; Chuzmarov V; Kurtenkov O
Int J Med Sci; 2013; 10(12):1674-82. PubMed ID: 24151439
[TBL] [Abstract][Full Text] [Related]
19. Signatures of anti-Thomsen - Friedenreich antigen antibody diversity in colon cancer patients.
Kurtenkov O; Bubina M; Klaamas K
Exp Oncol; 2018 Mar; 40(1):48-58. PubMed ID: 29600973
[TBL] [Abstract][Full Text] [Related]
20. The presence and significance of the Thomsen-Friedenreich antigen in breast cancer. I. Serological studies.
Newman RA; Klein PJ; Uhlenbruck G; Citoler P; Karduck D
J Cancer Res Clin Oncol; 1979 Feb; 93(2):181-8. PubMed ID: 374421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
